Volume 1 | Issue 3 | DOI: https://doi.org/10.33696/Signaling.1.015
Machine Learning for Healthcare: Emerging Challenges and Opportunities in Disease Diagnosis
- 1Mitchell Cancer Institute, University of South Alabama, Mobile, AL 36604, USA
Sachin Kumar Deshmukh, firstname.lastname@example.org
Received Date: July 28, 2020
Accepted Date: July 30, 2020
Deshmukh SK. Machine Learning for Healthcare: Emerging Challenges and Opportunities in Disease Diagnosis. J Cell Signal 2020;1(3):76-78.
Copyright: © 2020 Deshmukh SK. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Machine learning, Artificial neural network, Healthcare, Disease diagnosis, Heart diseases, Cancer
Although NK cells are recognized as effector lymphocytes of the innate immune system, they also regulate the adaptive immune response by releasing inflammatory cytokines and developing immunological memory. Unlike other lymphocytes such as T or B cells, NK cells do not express rearrangeable, antigen-specific receptors.
The transient receptor potential mucolipin 1 (TRPML1) is an endolysosomal channel belonging to the TRP family. Clinically, mutations of TRPML1 have been responsible for a severe lysosomal storage disorder called mucolipidosis type IV.
In order to implement the knowledge of cancer to monitor its evolution and setting, in the last decade, new minimally invasive and repeatable samples collection have been developed such as liquid biopsy.
Breast cancer is the second most common cancer worldwide, affecting nearly one in eight women. Accurate cancer staging is essential for determining the patient’s prognosis and for choosing the appropriate treatment.
However, the entire coagulation cascade is dysfunctional, in progressed chronic diabetes and cancer patients.